Zydus Lifesciences has partnered with Lupin Limited to co-market its innovative Semaglutide Injection, aimed at adults with type 2 diabetes mellitus ...

The Delhi High Court on Tuesday issued notice on a contempt of court petition alleging that the Central Drugs Standard Control Organisation (CDSCO) has failed t ...

I’ve been hearing a lot lately about how it’s “taking the easy way out” to use GLP-1s to lose weight. That stands for ...

As chronic conditions like obesity, diabetes and cancer surge in the US, the potential solutions often go back to diet. And ...

The study highlights that after stopping GLP-1 medications, many patients resume treatment or try alternatives, influencing weight management strategies.

Indian drugmakers Zydus Lifesciences and Lupin have signed a licensing and supply deal on Tuesday ​to co‑market semaglutide ...

A new clinical study suggests that successful root canal treatment may benefit more than just dental health. Patients treated for infected teeth showed improved blood sugar control, healthier ...

This month, the American Red Cross is encouraging more people to roll up their sleeves and donate blood by offering an ...

Eledon Pharmaceuticals, Inc. is rated a Strong Buy following positive phase 2 BESTOW results for tegoprubart. Read more on ELDN stock here.

Three beneficial owners filed open-market purchases this past week, each targeting a stock under significant pressure. General Atlantic accumulated shares in Alkami Technology (NASDAQ: ALKT) across ...

Despite causing irreversible damage, high cholesterol can be hard to spot – here's what experts say you should watch out for.